PreveCeutical Medical Inc (18H) - Cash Flow Conversion Efficiency
Based on the latest financial reports, PreveCeutical Medical Inc (18H) has a cash flow conversion efficiency ratio of 0.070x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-520.46K) by net assets (€-7.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PreveCeutical Medical Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how PreveCeutical Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PreveCeutical Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PreveCeutical Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Comanche International Public Company Limited
BK:COMAN
|
-0.055x |
|
Kaushalya Infrastructure Development Corporation Limited
NSE:KAUSHALYA
|
0.000x |
|
Resource Base Ltd
AU:RBX
|
-0.174x |
|
Cosmo Metals Ltd
AU:CMO
|
-0.035x |
|
Golden State Mining Ltd
AU:GSM
|
-1.834x |
|
Weaccess Group SA
PA:MLWEA
|
0.230x |
|
On The Beach Group PLC
LSE:OTB
|
0.335x |
|
Bubalus Resources Ltd
AU:BUS
|
-0.072x |
Annual Cash Flow Conversion Efficiency for PreveCeutical Medical Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of PreveCeutical Medical Inc from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-6.64 Million | €-426.69K | 0.064x | +25.09% |
| 2023-12-31 | €-5.78 Million | €-296.97K | 0.051x | -47.18% |
| 2022-12-31 | €-4.64 Million | €-450.99K | 0.097x | -6.35% |
| 2021-12-31 | €-4.10 Million | €-426.39K | 0.104x | +679.67% |
| 2020-12-31 | €-3.60 Million | €64.59K | -0.018x | -108.09% |
| 2019-12-31 | €-4.49 Million | €-993.94K | 0.222x | -93.32% |
| 2018-12-31 | €-2.29 Million | €-7.57 Million | 3.314x | -73.46% |
| 2017-12-31 | €-344.34K | €-4.30 Million | 12.485x | +181.02% |
| 2016-12-31 | €-296.06K | €-1.32 Million | 4.443x | -- |
About PreveCeutical Medical Inc
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disor… Read more